Role of Hydrophobic Substituents on the Terminal Nitrogen of Histamine in Receptor Binding and Agonist Activity: Development of an Orally Active Histamine Type 3 Receptor Agonist and Evaluation of Its Antistress Activity in Mice

Journal of Medicinal Chemistry
2010.0

Abstract

The terminal nitrogen atom of histamine was modified with lipophilic substituents to investigate the structure-activity relationship of histamine type 3 receptor (H3R) agonists. The introduction of an alkylated benzene rings maintained or increased the H3R binding affinity. The most potent compound, 4-(2-(4-tert-butylphenylthio)ethyl)-1H-imidazole, possessed in vivo agonistic activity, decreasing brain N(tau)-methylhistamine levels in mice after oral administration. It also exhibited antistress activity in the mouse resident-intruder test.

Knowledge Graph

Similar Paper

Role of Hydrophobic Substituents on the Terminal Nitrogen of Histamine in Receptor Binding and Agonist Activity: Development of an Orally Active Histamine Type 3 Receptor Agonist and Evaluation of Its Antistress Activity in Mice
Journal of Medicinal Chemistry 2010.0
4-Benzyl-1H-imidazoles with Oxazoline Termini as Histamine H<sub>3</sub>Receptor Agonists
Journal of Medicinal Chemistry 2008.0
Homologs of Histamine as Histamine H3 Receptor Antagonists: A New Potent and Selective H3 Antagonist, 4(5)-(5-Aminopentyl)-1H-imidazole
Journal of Medicinal Chemistry 1995.0
Potential histamine H2-receptor antagonists. 3. Methylhistamines
Journal of Medicinal Chemistry 1976.0
Synthesis and Histamine H1 Receptor Agonist Activity of a Series of 2-Phenylhistamines, 2-Heteroarylhistamines, and Analogs
Journal of Medicinal Chemistry 1995.0
Agonist/antagonist modulation in a series of 2-aryl benzimidazole H4 receptor ligands
Bioorganic &amp; Medicinal Chemistry Letters 2010.0
Piperidine variations in search for non-imidazole histamine H3 receptor ligands
Bioorganic &amp; Medicinal Chemistry 2008.0
4-(3-Aminoazetidin-1-yl)pyrimidin-2-amines as High-Affinity Non-imidazole Histamine H<sub>3</sub> Receptor Agonists with in Vivo Central Nervous System Activity
Journal of Medicinal Chemistry 2019.0
Synthesis and Structure−Activity Relationships of Conformationally Constrained Histamine H<sub>3</sub> Receptor Agonists
Journal of Medicinal Chemistry 2003.0
Synthesis and in Vitro Pharmacology of a Series of New Chiral Histamine H<sub>3</sub>-Receptor Ligands:  2-(RandS)-Amino-3-(1H-imidazol-4(5)-yl)propyl Ether Derivatives
Journal of Medicinal Chemistry 1999.0